TFA
Toth Financial Advisory’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
61,350
+1,825
| +3% | +$39.6K | 0.16% | 110 |
|
|
2025
Q1 | $1.44M | Buy |
59,525
+5,275
| +10% | +$128K | 0.17% | 108 |
|
|
2024
Q4 | $1.13M | Buy |
54,250
+3,750
| +7% | +$78.3K | 0.13% | 119 |
|
|
2024
Q3 | $1M | Buy |
+50,500
| New | +$1M | 0.12% | 122 |
|
|
2024
Q2 | – | Sell |
-33,800
| Closed | -$539K | – | 757 |
|
|
2024
Q1 | $539K | Buy |
33,800
+31,300
| +1,252% | +$499K | 0.07% | 160 |
|
|
2023
Q4 | $42K | Hold |
2,500
| – | – | 0.01% | 310 |
|
|
2023
Q3 | $29.2K | Hold |
2,500
| – | – | ﹤0.01% | 317 |
|
|
2023
Q2 | $33.6K | Hold |
2,500
| – | – | ﹤0.01% | 317 |
|
|
2023
Q1 | $41.5K | Buy |
2,500
+2,000
| +400% | +$33.2K | 0.01% | 293 |
|
|
2022
Q4 | $9.3K | Hold |
500
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $6K | Buy |
+500
| New | +$6K | ﹤0.01% | 523 |
|